Minimally invasive surfactant therapy versus intubation for surfactant administration in very low birth weight infants with respiratory distress syndrome
Background: Minimally invasive surfactant therapy (MIST) is a new mode of surfactant administration without intubation to spontaneously breathing preterm infants with respiratory distress syndrome (RDS). The aims of this study were to assess the feasibility, efficacy and safety of using MIST to give...
Main Authors: | Xing-An Wang, Lih-Ju Chen, Shan-Ming Chen, Pen-Hua Su, Jia-Yuh Chen |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2020-04-01
|
Series: | Pediatrics and Neonatology |
Online Access: | http://www.sciencedirect.com/science/article/pii/S187595721930542X |
Similar Items
-
Transient intubation for surfactant administration in the treatment of respiratory distress syndrome in extremely premature infants
by: Ji Won Koh, et al.
Published: (2018-10-01) -
Surfactant therapy for acute respiratory distress in infants
by: Corrado Moretti, et al.
Published: (2014-10-01) -
Less Invasive Surfactant Administration in Very Prematurely Born Infants
by: Sandeep Shetty, et al.
Published: (2021-07-01) -
Comparing the Efficacy of Surfactant Administration by Laryngeal Mask Airway and Endotracheal Intubation in Neonatal Respiratory Distress Syndrome
by: Manizheh Gharehbaghi, et al.
Published: (2018-07-01) -
Aerosolized Surfactant for Preterm Infants with Respiratory Distress Syndrome
by: Mandy Brasher, et al.
Published: (2021-06-01)